Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06790615Phase 2Completed
Phase 2, randomised, open-label trial in ganglion cyst (2 arms), sponsored by Benazir Bhutto Hospital. Primary endpoint: Recurrence of Ganglion Cyst at 6 months. Started Jun 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06790615.